| POLAR CAPITAL JAPAN VALUE S JPY DIS | RVI JAPÓN VALOR | 4,155415 | 20/08/2026 | 25,58% | 85,69% | ** |
| PRIVILEDGE - ROBECO EMERGING MARKETS EQUITIES BETA ENHANCED (USD) N CAP | RVI EMERGENTES | 15,195088 | 19/08/2026 | 25,58% | · | ND |
| AB SICAV I-EMERGING MARKETS OPPORTUNITIES PORTFOLIO A USD | RVI EMERGENTES | 21,128328 | 20/08/2026 | 25,57% | · | ND |
| BNP PARIBAS DISRUPTIVE TECHNOLOGY I USD CAP | RVI TECNOLOGÍA | 316,188682 | 20/08/2026 | 25,57% | 102,39% | *** |
| DWS INVEST ESG GLOBAL EMERGING MARKETS EQUITIES LD | RVI EMERGENTES | 184,720000 | 20/08/2026 | 25,57% | 70,63% | *** |
| SCHRODER ISF EMERGING ASIA I ACC EUR | RVI ASIA PACÍFICO | 105,573200 | 20/08/2026 | 25,57% | 80,64% | **** |
| DWS INVEST ESG GLOBAL EMERGING MARKETS EQUITIES USD LC | RVI EMERGENTES | 168,384556 | 20/08/2026 | 25,56% | 72,17% | *** |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) SGD | RVI BIOTECNOLOGÍA | 46,157470 | 20/08/2026 | 25,56% | 106,51% | ***** |
| GOLDMAN SACHS GLOBAL FUTURE ECONOMIC SECURITY EQUITY PORTFOLIO BASE USD CAP | RVI GLOBAL | 16,659533 | 20/08/2026 | 25,56% | 81,40% | ***** |
| POLAR CAPITAL BIOTECHNOLOGY S EUR DIS | RVI BIOTECNOLOGÍA | 74,420000 | 20/08/2026 | 25,56% | 112,81% | ***** |
| GOLDMAN SACHS EMERGING MARKETS CORE EQUITY PORTFOLIO BASE (SNAP) USD CAP | RVI EMERGENTES | 15,546614 | 20/08/2026 | 25,55% | 75,07% | *** |
| PICTET - CLEAN ENERGY TRANSITION I DY USD | RVI ENERGÍA | 258,856262 | 20/08/2026 | 25,55% | · | **** |
| PICTET - CLEAN ENERGY TRANSITION I USD | RVI ENERGÍA | 259,301430 | 20/08/2026 | 25,55% | 71,64% | **** |
| AZVALOR LUX SICAV - AZVALOR INTERNATIONAL-Z | RVI GLOBAL | 0,029000 | 19/08/2026 | 25,54% | 49,79% | *** |
| DPAM L EQUITIES ARTIFICIAL INTELLIGENCE A DIS | RVI TECNOLOGÍA | 163,610000 | 20/08/2026 | 25,54% | · | ND |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) HKD | RVI BIOTECNOLOGÍA | 5,280276 | 20/08/2026 | 25,54% | 106,33% | ***** |
| JANUS HENDERSON HF - BIOTECHNOLOGY A2 EUR | RVI BIOTECNOLOGÍA | 35,590000 | 20/08/2026 | 25,54% | 110,59% | **** |
| PRIVILEDGE - ROBECO EMERGING MARKETS EQUITIES BETA ENHANCED (USD) M CAP | RVI EMERGENTES | 15,176476 | 19/08/2026 | 25,54% | · | ND |
| ROBECO EMERGING MARKETS EQUITIES F EUR | RVI EMERGENTES | 309,830000 | 20/08/2026 | 25,54% | 84,83% | *** |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) USD | RVI BIOTECNOLOGÍA | 63,376423 | 20/08/2026 | 25,53% | 106,45% | ***** |
